Genpact Limited: Q3 2023 Form 10-Q Summary
Business context and reporting period
Genpact is a global professional services firm providing digitally enabled operations, analytics, consulting, automation and information technology services. It had more than 127,000 employees across more than 35 countries. The filing covers the unaudited quarter and nine months ended September 30, 2023, compared primarily with the corresponding 2022 periods.
Key financial metrics
| Metric | Q3 2023 | Q3 2022 | Change |
|---|
| Net revenues | $1,135.8 million | $1,111.0 million | 2.2% |
| Gross profit | $402.8 million | $393.8 million | 2.3% |
| Gross margin | 35.5% | 35.4% | 0.1 percentage points |
| Income from operations | $165.7 million | $130.8 million | 26.6% |
| Operating margin | 14.6% | 11.8% | 2.8 percentage points |
| Net income | $117.6 million | $95.8 million | 22.7% |
| Diluted EPS | $0.64 | $0.51 | 25.5% |
| Adjusted income from operations | $195.0 million | $188.8 million | 3.3% |
| Adjusted operating margin | 17.2% | 17.1% | 0.1 percentage points |
| Metric | Nine months 2023 | Nine months 2022 | Change |
|---|
| Net revenues | $3,330.6 million | $3,268.6 million | 1.9% |
| Gross margin | 34.9% | 35.2% | (0.3) percentage points |
| Income from operations | $468.1 million | $374.4 million | 25.0% |
| Operating margin | 14.1% | 11.5% | 2.6 percentage points |
| Net income | $339.9 million | $263.7 million | 28.9% |
| Diluted EPS | $1.83 | $1.40 | 30.7% |
| Adjusted income from operations | $559.9 million | $531.6 million | 5.3% |
| Adjusted operating margin | 16.8% | 16.3% | 0.5 percentage points |
Revenue and operating performance
- Q3 Data-Tech-AI revenue declined 2.0% to $499.7 million, reflecting pressure on short-cycle discretionary technology spending, particularly in Financial Services and Consumer and Healthcare.
- Q3 Digital Operations revenue increased 5.8% to $636.1 million, driven primarily by ramp-ups from recently signed large deals.
- Q3 segment revenue increased 6.1% in Financial Services and 3.6% in High Tech and Manufacturing, while Consumer and Healthcare declined 1.9%.
- Q3 operating margin benefited from improved utilization, operating leverage, lower amortization and the absence of the $21.4 million held-for-sale impairment recorded in the prior-year quarter. Wage inflation remained a partial offset.
- For the nine months, revenue growth was led by Financial Services, up 6.4%, and High Tech and Manufacturing, up 3.1%. Consumer and Healthcare declined 2.5%, partly due to lower discretionary spending, lengthening deal cycles and the divestiture of a business.
- SG&A declined 3.7% for the nine months, while stock-based compensation increased to $63.9 million from $54.9 million.
Cash flow, liquidity and debt
| Metric | September 30, 2023 | December 31, 2022 |
|---|
| Cash and cash equivalents | $541.0 million | $646.8 million |
| Short-term borrowings | $55.0 million | $151.0 million |
| Long-term debt, including current portion | $1,256.6 million | $1,275.3 million |
| Shareholders’ equity | $2,009.5 million | $1,826.2 million |
- Operating cash flow for the nine months was $298.9 million, compared with $214.0 million in the prior-year period.
- Investing cash use was $60.1 million, including $39.9 million for property, equipment and intangible assets and $19.5 million related to the divestiture.
- Financing cash use was $338.3 million, including $150.5 million of share repurchases and $75.2 million of dividends.
- Cash declined by $99.4 million during the nine months, including a $6.3 million adverse foreign-exchange effect.
- The company had $508.8 million outstanding under its term loan, $399.3 million of 2019 Senior Notes due December 2024, and $348.5 million of 2021 Senior Notes due April 2026. The term loan and revolving facility mature in December 2027.
- The $650.0 million revolving facility had $55.0 million of funded borrowings outstanding at September 30, 2023. Management stated that all applicable debt covenants were satisfied.
- Management expects operating cash flow, cash reserves and debt capacity to fund operations, growth, dividends and additional repurchases for the next twelve months and foreseeable future.
Material changes, outlook and unusual items
- The company completed the divestiture of a previously held-for-sale Consumer and Healthcare business in the first quarter of 2023. The transaction produced a $0.8 million loss in the nine-month period and required $19.5 million of cash.
- A $4.9 million gain from terminating an abandoned lease was recorded in the nine months ended September 30, 2023. There was no incremental restructuring charge in Q3 2023; the comparable 2022 period included a $38.8 million restructuring charge.
- The effective tax rate increased to 24.1% in Q3 and 23.4% for the nine months, primarily because of changes in the jurisdictional mix of income and higher tax rates in certain jurisdictions.
- Interest costs remain sensitive to Term SOFR and debt ratings. The weighted average debt rate, including interest-rate swaps, rose to 4.1% in Q3 from 3.0% in the prior-year quarter.
- Management identified continued macroeconomic and geopolitical uncertainty, wage inflation, slower discretionary client spending, foreign-exchange volatility, competition, employee retention, cybersecurity and data-protection risks, and the pace of adoption of artificial intelligence as material considerations.
- Potential contingencies include an Indian tax assessment totaling approximately $111.4 million, excluding subsequent penalties and interest, and uncertainty regarding possible retrospective application of an Indian employee-benefit ruling. No reserve was recorded because management believes its positions are more likely than not to prevail or the amount cannot yet be reliably estimated.
- The board declared a Q4 2023 dividend of $0.1375 per share, payable December 22, 2023. The share-repurchase authorization had $474.5 million remaining at September 30, 2023.
Most important facts for investors to verify
- Whether Data-Tech-AI demand and discretionary technology spending recover, particularly in Financial Services and Consumer and Healthcare.
- The conversion and profitability of recently signed large deals and the sustainability of Digital Operations growth.
- Gross-margin trends amid wage inflation, headcount growth, travel costs and utilization changes.
- Cash conversion, accounts receivable growth and the effect of dividends and share repurchases on liquidity.
- Refinancing or repayment plans for the $399.3 million of 2019 Senior Notes due December 2024.
- Exposure to higher SOFR, debt-rating changes and compliance with the 3x net-debt-to-EBITDA and greater-than-3x interest-coverage covenants.
- Potential outcomes of the Indian tax assessment and employee-benefit contingency.
- Execution of AI-related investments, cybersecurity controls and protection of client data.
